Comparison of the efficacy of first-line combinations for metastatic clear cell renal cell carcinoma: A propensity score-matched analysis of Japanese multicenter database

被引：0

作者：

Yanagisawa, T. ^{[1
]}

Mori, K. ^{[1
]}

Fukuokaya, W. ^{[1
]}

Kawada, T. ^{[2
]}

Katayama, S. ^{[2
]}

Uchimoto, T. ^{[3
]}

Tsujino, T. ^{[3
]}

Nishimura, K. ^{[3
]}

Adachi, T. ^{[4
]}

Toyoda, S. ^{[5
]}

Komura, K. ^{[3
]}

Takahara, K. ^{[6
]}

Hashimoto, T. ^{[4
]}

Fujita, K. ^{[5
]}

Azuma, H. ^{[3
]}

Ohno, Y. ^{[4
]}

Shiroki, R. ^{[6
]}

Uemura, H. ^{[5
]}

Araki, M. ^{[2
]}

Kimura, T. ^{[1
]}

机构：

[1] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan

[2] Okayama Univ, Grad Sch Med, Dept Urol, Okayama, Japan

[3] Osaka Med & Pharmaceut Univ, Dept Urol, Osaka, Japan

[4] Tokyo Med Univ, Dept Urol, Tokyo, Japan

[5] Kindai Univ, Fac Med, Dept Urol, Osaka, Japan

[6] Fujita Hlth Univ, Sch Med, Dept Urol, Nagoya, Aichi, Japan

来源：

EUROPEAN UROLOGY | 2024年 / 85卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

A0836

引用

页码：S1856 / S1857

页数：2

共 50 条

[21] Update on First-Line Combination Treatment Approaches in Metastatic Clear-Cell Renal Cell Carcinoma
Bryce R. Christensen
Yasmin M. Hajja
Vadim Koshkin
Pedro C. Barata
Current Treatment Options in Oncology, 2021, 22
[22] Update on First-Line Combination Treatment Approaches in Metastatic Clear-Cell Renal Cell Carcinoma
Christensen, Bryce R.
Hajja, Yasmin M.
Koshkin, Vadim
Barata, Pedro C.
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (02)
[23] First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among experts
Aeppli, S.
Schmaus, M.
Eisen, T.
Escudier, B.
Gruenwald, V
Larkin, J.
McDermott, D.
Oldenburg, J.
Porta, C.
Rini, B., I
Schmidinger, M.
Sternberg, C. N.
Rothermundt, C.
Putora, P. M.
ESMO OPEN, 2021, 6 (01)
[24] Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes
Rothermundt, Christian
Bailey, Alexandra
Cerbone, Linda
Eisen, Tim
Escudier, Bernard
Gillessen, Silke
Gruenwald, Viktor
Larkin, James
McDermott, David
Oldenburg, Jan
Porta, Camillo
Rini, Brian
Schmidinger, Manuela
Sternberg, Cora
Putora, Paul M.
ONCOLOGIST, 2015, 20 (09): : 1028 - 1035
[25] First-line treatment of metastatic renal cell carcinoma
Bruchbacher, Andreas
Netsch, Christopher
Gross, Andreas J. J.
UROLOGIE, 2023, 62 (08): : 830 - 839
[26] First-line therapy for metastatic renal cell carcinoma
Sawhney, Paramvir
Suyanto, Suyanto
Michael, Agnieszka
Pandha, Hardev
JOURNAL OF CLINICAL UROLOGY, 2024, 17 (02) : 190 - 200
[27] Renal cell carcinoma treatment after first-line combinations
Porta, Camillo
Schmidinger, Manuela
LANCET ONCOLOGY, 2019, 20 (10): : 1332 - 1334
[28] Immunotherapy-based combinations versus standard first-line treatment for metastatic clear cell renal cell carcinoma: a systematic review and meta-analysis
Sebastiano Buti
Fausto Petrelli
Antonio Ghidini
Ivano Vavassori
Umberto Maestroni
Melissa Bersanelli
Clinical and Translational Oncology, 2020, 22 : 1657 - 1663
[29] Immunotherapy-based combinations versus standard first-line treatment for metastatic clear cell renal cell carcinoma: a systematic review and meta-analysis
Buti, Sebastiano
Petrelli, Fausto
Ghidini, Antonio
Vavassori, Ivano
Maestroni, Umberto
Bersanelli, Melissa
CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (09): : 1657 - 1663
[30] Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium Analysis
Gupta, Mehul
Wells, Connor
Regan, Meredith M.
Xie, Wanling
Navani, Vishal
Saliby, Renee Maria
Basa, Naveen S.
Donskov, Frede
Yuasa, Takeshi
Takemura, Kosuke
Kollmannsberger, Christian K.
Crumbaker, Megan
Lalani, Aly-Khan A.
Powles, Thomas
Ebrahimi, Hedyeh
Mckay, Rana R.
Lee, Jae-Lyun
Kanesvaran, Ravindran
Choueiri, Toni K.
Heng, Daniel Y. C.
EUROPEAN UROLOGY ONCOLOGY, 2025, 8 (01): : 171 - 178

← 1 2 3 4 5 →